[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

HK1021320A1 - Liposomes containing a cisplatin compound - Google Patents

Liposomes containing a cisplatin compound

Info

Publication number
HK1021320A1
HK1021320A1 HK00100177A HK00100177A HK1021320A1 HK 1021320 A1 HK1021320 A1 HK 1021320A1 HK 00100177 A HK00100177 A HK 00100177A HK 00100177 A HK00100177 A HK 00100177A HK 1021320 A1 HK1021320 A1 HK 1021320A1
Authority
HK
Hong Kong
Prior art keywords
compound
liposomes
liposomes containing
cisplatin compound
entrapped
Prior art date
Application number
HK00100177A
Other languages
English (en)
Inventor
Robert M Abra
Karen Reis
Original Assignee
Sequus Pharm Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sequus Pharm Inc filed Critical Sequus Pharm Inc
Publication of HK1021320A1 publication Critical patent/HK1021320A1/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/127Liposomes
    • A61K9/1271Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/28Compounds containing heavy metals
    • A61K31/282Platinum compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/555Heterocyclic compounds containing heavy metals, e.g. hemin, hematin, melarsoprol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/24Heavy metals; Compounds thereof
    • A61K33/243Platinum; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
HK00100177A 1996-08-23 2000-01-11 Liposomes containing a cisplatin compound HK1021320A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US2435096P 1996-08-23 1996-08-23
PCT/US1997/014541 WO1998007409A1 (en) 1996-08-23 1997-08-19 Liposomes containing a cisplatin compound

Publications (1)

Publication Number Publication Date
HK1021320A1 true HK1021320A1 (en) 2000-06-09

Family

ID=21820133

Family Applications (1)

Application Number Title Priority Date Filing Date
HK00100177A HK1021320A1 (en) 1996-08-23 2000-01-11 Liposomes containing a cisplatin compound

Country Status (13)

Country Link
US (2) US5945122A (es)
EP (1) EP0929293B1 (es)
JP (1) JP2001501173A (es)
AT (1) ATE252372T1 (es)
AU (1) AU714992B2 (es)
CA (1) CA2263455C (es)
DE (1) DE69725747T2 (es)
DK (1) DK0929293T3 (es)
ES (1) ES2208946T3 (es)
HK (1) HK1021320A1 (es)
PT (1) PT929293E (es)
TW (1) TW483759B (es)
WO (1) WO1998007409A1 (es)

Families Citing this family (146)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE506164C2 (sv) * 1995-10-09 1997-11-17 Medscand Medical Ab Instrumentarium för behandling av urininkontinens hos kvinnor
US5972379A (en) * 1995-02-14 1999-10-26 Sequus Pharmaceuticals, Inc. Liposome composition and method for administering a quinolone
JP2001501173A (ja) * 1996-08-23 2001-01-30 アルザ コーポレイション シスプラチン化合物を含有するリポソーム
FR2759293B1 (fr) * 1997-02-11 1999-04-30 Ethypharm Lab Prod Ethiques Microgranules contenant du cisplatine, procede de fabrication, preparation pharmaceutique et utilisation en polychimiotherapie ou en association avec une radiotherapie
DE19724796A1 (de) * 1997-06-06 1998-12-10 Max Delbrueck Centrum Mittel zur Antitumortherapie
AU774715B2 (en) 1998-09-16 2004-07-08 Alza Corporation Liposome-entrapped topoisomerase inhibitors
US20050084524A1 (en) * 1998-09-30 2005-04-21 Alza Corporation Method for potentiating activity of a chemotherapeutic drug
WO2000074633A2 (en) * 1999-06-09 2000-12-14 Ethicon, Inc. Method and apparatus for adjusting flexible areal polymer implants
US6932759B2 (en) 1999-06-09 2005-08-23 Gene W. Kammerer Surgical instrument and method for treating female urinary incontinence
US7121997B2 (en) * 1999-06-09 2006-10-17 Ethicon, Inc. Surgical instrument and method for treating female urinary incontinence
US7226407B2 (en) 1999-06-09 2007-06-05 Ethicon, Inc. Surgical instrument and method for treating female urinary incontinence
US6511676B1 (en) 1999-11-05 2003-01-28 Teni Boulikas Therapy for human cancers using cisplatin and other drugs or genes encapsulated into liposomes
AU2136501A (en) * 1999-12-10 2001-06-18 Celator Technologies Inc. Lipid carrier compositions with protected surface reactive functions
AU2001234670B2 (en) 2000-01-28 2005-05-19 Alza Corporation Liposomes containing an entrapped compound in supersaturated solution
US7131943B2 (en) * 2000-03-09 2006-11-07 Ethicon, Inc. Surgical instrument and method for treating organ prolapse conditions
DE10019604C2 (de) * 2000-04-20 2002-06-27 Ethicon Gmbh Implantat
JP2001336528A (ja) * 2000-05-25 2001-12-07 Ntn Corp 磁気浮上装置
US7025063B2 (en) * 2000-09-07 2006-04-11 Ams Research Corporation Coated sling material
WO2002028386A1 (fr) * 2000-10-03 2002-04-11 Debiopharm S.A. Procede de preparation de microspheres contenant une substance soluble dans l'eau
ATE319428T1 (de) * 2000-12-07 2006-03-15 Univ Utrecht Holding Bv Zusammensetzung zur behandlung von entzündlichen erkrankungen
US6612977B2 (en) 2001-01-23 2003-09-02 American Medical Systems Inc. Sling delivery system and method of use
US6802807B2 (en) * 2001-01-23 2004-10-12 American Medical Systems, Inc. Surgical instrument and method
US6641525B2 (en) 2001-01-23 2003-11-04 Ams Research Corporation Sling assembly with secure and convenient attachment
DE10107165A1 (de) * 2001-02-15 2002-08-29 Max Planck Gesellschaft Thermolabiles Liposom mit geregelter Freigabetemperatur
WO2002078672A2 (en) * 2001-03-30 2002-10-10 Alza Corporation Liposomal tumor necrosis factor compositions and methods
EP1424898A4 (en) * 2001-08-20 2008-04-02 Transave Inc TREATMENT OF CANCER BY INHALATION OF STABLE FORMULATIONS CONTAINING PLATINUM
EP1424889A4 (en) * 2001-08-20 2008-04-02 Transave Inc PROCESS FOR TREATING LUNG CANCERS
CA2461219A1 (en) * 2001-09-24 2003-04-03 Tosk, Inc. Reduced toxicity cisplatin formulations and methods for using the same
US7087065B2 (en) * 2001-10-04 2006-08-08 Ethicon, Inc. Mesh for pelvic floor repair
PT1443900E (pt) * 2001-11-13 2012-08-01 Celator Pharmaceuticals Inc Composições de veículo lipídico com estabilidade melhorada no sangue
US6476068B1 (en) 2001-12-06 2002-11-05 Pharmacia Italia, S.P.A. Platinum derivative pharmaceutical formulations
US7131944B2 (en) 2002-03-01 2006-11-07 Ethicon, Inc. Method and apparatus for treating pelvic organ prolapses in female patients
AU2003230600B2 (en) * 2002-03-05 2009-06-04 Transave, Inc. An inhalation system for prevention and treatment of intracellular infections
US20110142922A1 (en) * 2002-04-30 2011-06-16 Ferndale Ip, Inc. Stabilized composition and method for dermatological treatment
US20030215493A1 (en) * 2002-04-30 2003-11-20 Patel Pravin M. Composition and method for dermatological treatment
US20090060992A1 (en) * 2002-05-08 2009-03-05 University Of Central Florida Research Foundation, Inc., Preparation of magneto-vesicles with DOPE/DDAB layers
JP3415131B1 (ja) 2002-06-03 2003-06-09 メビオファーム株式会社 リポソーム製剤
US20040022842A1 (en) * 2002-06-03 2004-02-05 Mebiopharm Co., Ltd. Liposome preparations containing oxaliplatin
US20050152962A1 (en) * 2002-06-12 2005-07-14 Metselaar Josbert M. Composition for treatment of inflammatory disorders
US9186322B2 (en) * 2002-08-02 2015-11-17 Insmed Incorporated Platinum aggregates and process for producing the same
WO2004054499A2 (en) * 2002-08-02 2004-07-01 Transave, Inc. Platinum aggregates and process for producing the same
EP1393720A1 (en) * 2002-08-27 2004-03-03 Universiteit Utrecht Vesicle-encapsulated corticosteroids for treatment of cancer
US7879351B2 (en) * 2002-10-29 2011-02-01 Transave, Inc. High delivery rates for lipid based drug formulations, and methods of treatment thereof
SI1581236T1 (sl) * 2002-10-29 2014-02-28 Insmed Incorporated Princeton Corporate Plaza Zadržano sproščanje antiinfektivov
US7718189B2 (en) * 2002-10-29 2010-05-18 Transave, Inc. Sustained release of antiinfectives
JP2006514016A (ja) * 2002-11-26 2006-04-27 ギリアード サイエンシーズ, インコーポレイテッド リポソーム処方物
KR20050090987A (ko) * 2002-12-19 2005-09-14 알자 코포레이션 혈관신생 조직 성장 치료 방법
DE60330745D1 (de) * 2002-12-31 2010-02-11 Bharat Serums & Vaccines Ltd Nicht-pegylierte lang-zirkulierende Liposome
KR20050115251A (ko) * 2003-02-28 2005-12-07 알자 코포레이션 리포좀-유도된 보체의 활성화를 감소시키기 위한 리포좀조성물
US7968115B2 (en) * 2004-03-05 2011-06-28 Board Of Regents, The University Of Texas System Liposomal curcumin for treatment of cancer
EP1610763A2 (en) * 2003-03-31 2006-01-04 Yissum Research Development Company Of The Hebrew University Of Jerusalem Stable liposomes or micelles comprising a sphingolipid and a peg-lipopolymer
JP2006528985A (ja) * 2003-05-19 2006-12-28 バクスター・インターナショナル・インコーポレイテッド 1つ以上の界面改変剤でコーティングされた、抗癲癇剤または免疫抑制剤を含有する固体粒子
WO2004103344A1 (en) * 2003-05-20 2004-12-02 Aronex Pharmaceuticals, Inc. Combination chemotherapy comprising a liposomal platinum complex
EP1661556A4 (en) * 2003-08-20 2010-05-19 Ajinomoto Kk MEDICAL PREPARATION WITH IMPROVED RESOLUTION CHARACTERISTICS
CN100471493C (zh) * 2003-12-17 2009-03-25 梅比欧法姆股份有限公司 含有奥沙利铂的脂质体制剂
US8784881B2 (en) 2004-03-05 2014-07-22 Board Of Regents, The University Of Texas System Liposomal curcumin for treatment of diseases
US20080103213A1 (en) * 2004-03-05 2008-05-01 Board Of Regents, The University Of Texas System Liposomal curcumin for treatment of neurofibromatosis
AU2005223654A1 (en) * 2004-03-18 2005-09-29 Transave, Inc. Administration of cisplatin by inhalation
US20070065522A1 (en) * 2004-03-18 2007-03-22 Transave, Inc. Administration of high potency platinum compound formulations by inhalation
US8047982B2 (en) * 2004-05-07 2011-11-01 Ethicon, Inc. Mesh tape with wing-like extensions for treating female urinary incontinence
CN101001633A (zh) * 2004-05-21 2007-07-18 特兰萨夫公司 肺病和肺病前期病症的治疗
WO2006015031A2 (en) * 2004-07-28 2006-02-09 Ethicon, Inc. Minimally invasive medical implant and insertion device and method for using the same
JP2006056807A (ja) * 2004-08-18 2006-03-02 Konica Minolta Medical & Graphic Inc 光線力学療法製剤
JP4715133B2 (ja) * 2004-08-26 2011-07-06 コニカミノルタエムジー株式会社 抗腫瘍リポソーム製剤およびその製造方法
JP2006069929A (ja) * 2004-08-31 2006-03-16 Konica Minolta Medical & Graphic Inc 真菌症治療製剤およびその製造方法
CA2579695A1 (en) 2004-09-09 2006-03-16 Yissum Research Development Company Of The Hebrew University Of Jerusale M Liposomal compositions of glucocorticoid and glucocorticoid derivatives
US7527588B2 (en) * 2004-09-15 2009-05-05 Ethicon, Inc. System and method for surgical implant placement
MX2007004955A (es) * 2004-11-08 2007-06-14 Transave Inc Metodo de tratar cancer con formulaciones de compeusto de platino a base de lipido administradas intraperitonealmente.
US7481314B2 (en) * 2005-02-02 2009-01-27 Ethicon, Inc. Packaging assembly for surgical mesh implants
JP2006248978A (ja) * 2005-03-10 2006-09-21 Mebiopharm Co Ltd 新規なリポソーム製剤
US20060283742A1 (en) * 2005-06-16 2006-12-21 Canel Lightning Co. Ltd. Multi-lamp display packaging for lamps with collapsible lampshades
CN1913508B (zh) * 2005-08-08 2010-05-05 华为技术有限公司 基于正交频分复用的信号调制方法及其调制装置
US7846445B2 (en) * 2005-09-27 2010-12-07 Amunix Operating, Inc. Methods for production of unstructured recombinant polymers and uses thereof
US20070191272A1 (en) * 2005-09-27 2007-08-16 Stemmer Willem P Proteinaceous pharmaceuticals and uses thereof
US7855279B2 (en) 2005-09-27 2010-12-21 Amunix Operating, Inc. Unstructured recombinant polymers and uses thereof
US20090099031A1 (en) * 2005-09-27 2009-04-16 Stemmer Willem P Genetic package and uses thereof
US9107824B2 (en) * 2005-11-08 2015-08-18 Insmed Incorporated Methods of treating cancer with high potency lipid-based platinum compound formulations administered intraperitoneally
WO2007056264A2 (en) * 2005-11-08 2007-05-18 Transave, Inc. Methods of treating cancer with high potency lipid-based platinum compound formulations administered intraperitoneally
WO2007056236A2 (en) * 2005-11-08 2007-05-18 Transave, Inc. Methods of treating cancer with lipid-based platinum compound formulations administered intravenously
WO2007056263A2 (en) * 2005-11-08 2007-05-18 Transave, Inc. Methods of treating cancer with high potency lipid-based platinum compound formulations administered intravenously
WO2007064658A2 (en) * 2005-11-30 2007-06-07 Transave, Inc. Safe and effective methods of administering therapeutic agents
AU2006322076C1 (en) 2005-12-08 2013-11-14 Insmed Incorporated Lipid-based compositions of antiinfectives for treating pulmonary infections
JP5738516B2 (ja) 2005-12-30 2015-06-24 ゼンサン (シャンハイ) サイエンス アンド テクノロジー リミテッド 心機能改善のためのニューレグリンの徐放
US20090169610A1 (en) * 2006-02-03 2009-07-02 Noboru Yamazaki Liposome Preparation
US20100034874A1 (en) * 2006-12-08 2010-02-11 Katayama Chemical Industries Co., Ltd. Liposome encapsulating ammine-platinum complex at high concentration, and method for production of the liposome
US8834920B2 (en) 2006-12-21 2014-09-16 Alza Corporation Liposome composition for targeting egfr receptor
WO2008079973A2 (en) * 2006-12-21 2008-07-03 Centocor, Inc. Egfr binding peptides and uses thereof
US8278415B2 (en) 2006-12-21 2012-10-02 Centocor, Inc. Dimeric high affinity EGFR constructs and uses thereof
US20100196455A1 (en) * 2007-05-04 2010-08-05 Transave, Inc. Compositions of Multicationic Drugs for Reducing Interactions with Polyanionic Biomolecules and Methods of Use Thereof
US9114081B2 (en) 2007-05-07 2015-08-25 Insmed Incorporated Methods of treating pulmonary disorders with liposomal amikacin formulations
US9333214B2 (en) 2007-05-07 2016-05-10 Insmed Incorporated Method for treating pulmonary disorders with liposomal amikacin formulations
US9119783B2 (en) 2007-05-07 2015-09-01 Insmed Incorporated Method of treating pulmonary disorders with liposomal amikacin formulations
TW200916094A (en) * 2007-06-27 2009-04-16 Poniard Pharmaceuticals Inc Stabilized picoplatin dosage form
BRPI0815416A2 (pt) * 2007-08-15 2014-10-21 Amunix Inc Composições e métodos para modificar propriedades de polipeptídeos biologicamente ativos
ES2550759T3 (es) 2007-08-17 2015-11-12 Celator Pharmaceuticals, Inc. Formulaciones farmacológicas de platino mejoradas
WO2009040426A1 (en) 2007-09-28 2009-04-02 Universitätsspital Basel Immunoliposomes for treatment of cancer
US20090130017A1 (en) * 2007-11-19 2009-05-21 Searete Llc Targeted short-lived drug delivery
TWI468188B (zh) * 2008-01-30 2015-01-11 Univ Tokushima Anti-cancer effect enhancers consisting of oxaliplatin liposomal preparations and anticancer agents comprising the formulation
KR20190049930A (ko) * 2008-05-23 2019-05-09 더 유니버시티 오브 브리티쉬 콜롬비아 리포좀 나노입자에 사용하기 위한 변형된 약물
US20100035853A1 (en) * 2008-08-07 2010-02-11 Hyogo College Of Medicine Method for preventing or treating cisplatin-induced nephrotoxicity
US9322831B2 (en) * 2008-09-23 2016-04-26 The Johns Hopkins University DDX3 as a biomarker for cancer and methods related thereto
US8449573B2 (en) 2008-12-05 2013-05-28 Boston Scientific Scimed, Inc. Insertion device and method for delivery of a mesh carrier
MX2011008094A (es) 2009-02-03 2012-02-13 Amunix Operating Inc Polipeptidos recombinantes extendidos y composiciones que comprenden los mismos.
EP2228059A1 (en) 2009-03-12 2010-09-15 Universitätsspital Basel Chemotherapeutic composition for the treatment of cancer
US20120148661A1 (en) * 2009-04-15 2012-06-14 Poniard Pharmaceuticals, Inc. High bioavailability oral picoplatin anti-cancer therapy
US8968334B2 (en) 2009-04-17 2015-03-03 Boston Scientific Scimed, Inc. Apparatus for delivering and anchoring implantable medical devices
AU2010258892B2 (en) 2009-06-08 2015-08-13 Amunix Operating Inc. Growth hormone polypeptides and methods of making and using same
CA2764108A1 (en) 2009-06-08 2010-12-16 Amunix Operating Inc. Glucose-regulating polypeptides and methods of making and using same
WO2010143193A1 (en) 2009-06-11 2010-12-16 Yissum Research Development Company Of The Hebrew University Of Jerusalem, Ltd. Targeted liposomes comprising n-containing bisphosphonates and uses thereof
AU2010290131C1 (en) 2009-08-24 2015-12-03 Amunix Operating Inc. Coagulation factor VII compositions and methods of making and using same
DK177529B1 (en) * 2009-10-23 2013-09-08 Bio Bedst Aps Liposomes with improved storage stability
JP2013509422A (ja) 2009-10-30 2013-03-14 シーエヌエス セラピューティクス,インク. 改良されたニュールツリン分子
US9301750B2 (en) * 2009-11-03 2016-04-05 Boston Scientific Scimed, Inc. Device and method for delivery of mesh-based devices
US20130052259A1 (en) 2010-02-01 2013-02-28 Yechezkel Barenholz Liposomes comprising amphipathic drugs and method for their preparation
WO2012065044A2 (en) 2010-11-12 2012-05-18 Purdue Research Foundation Treating bladder tumor cells using fibronectin attachment protein as a target
EP2508176A1 (en) 2011-04-08 2012-10-10 Lipotarg Gmbh Novel combination treatment of cancer
SI2731591T1 (sl) 2011-07-13 2021-02-26 Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. Liposomi ko-inkapsulirajoči bifosfonat in amfipatično sredstvo
US20150004219A1 (en) 2012-02-02 2015-01-01 Yissum Research Development Company Of The Hebrew University Of Jerusalem, Ltd. Stable liposomes for drug delivery
HRP20221531T1 (hr) 2012-02-15 2023-02-17 Bioverativ Therapeutics Inc. Pripravci faktora viii i postupci dobivanja i korištenja istih
JP6383666B2 (ja) 2012-02-15 2018-08-29 バイオベラティブ セラピューティクス インコーポレイテッド 組換え第viii因子タンパク質
EP2852391B1 (en) 2012-05-21 2021-11-17 Insmed Incorporated Systems for treating pulmonary infections
WO2013184938A2 (en) 2012-06-08 2013-12-12 Alkermes. Inc. Fusion polypeptides comprising mucin-domain polypeptide linkers
EP2874605A1 (en) 2012-07-18 2015-05-27 Onyx Therapeutics, Inc. Liposomal compositions of epoxyketone-based proteasome inhibitors
MA37931A1 (fr) * 2012-08-13 2016-07-29 Teni Boulikas Procédés améliorés permettant de traiter un cancer avec une toxicité rénale réduite
ES2848025T3 (es) 2012-09-04 2021-08-05 Eleison Pharmaceuticals LLC Prevención de la recidiva pulmonar del cáncer con cisplatino complejado con lípidos
WO2014052634A1 (en) * 2012-09-27 2014-04-03 The University Of North Carolina At Chapel Hill Lipid coated nanoparticles containing agents having low aqueous and lipid solubilities and methods thereof
US10124066B2 (en) 2012-11-29 2018-11-13 Insmed Incorporated Stabilized vancomycin formulations
US9556214B2 (en) * 2012-12-19 2017-01-31 Placon Therapeutics, Inc. Compounds, compositions, and methods for the treatment of cancers
BR112015022415A2 (pt) * 2013-03-13 2017-07-18 Mallinckrodt Llc composições de cisplatina lipossômica para terapia contra câncer
WO2014159760A1 (en) * 2013-03-13 2014-10-02 Mallinckrodt Llc Liposome oxaliplatin compositions for cancer therapy
TW202003554A (zh) 2013-08-14 2020-01-16 美商百歐維拉提夫治療公司 因子viii-xten融合物及其用途
US9987375B2 (en) * 2013-09-23 2018-06-05 Amirhossein Sahebkar Method and composition for treatment of dyslipidemia and other diseases
MX2016012168A (es) 2014-03-25 2017-04-25 The Government Of The Us Secretary Of The Army Formulacion adyuvante no toxica que comprende una composicion de liposoma que contiene monofosforil-lipido a (mpla) y una saponina.
SI3466432T1 (sl) 2014-05-15 2020-11-30 Insmed Incorporated Postopek zdravljenja pljučnih netuberkuloznih mikobakterijskih okužb
EP3270898B1 (en) 2015-03-17 2021-05-05 Lipomedix Pharmaceuticals Ltd. Methods for the treatment of bladder cancer
MX2018001497A (es) 2015-08-03 2018-05-15 Bioverativ Therapeutics Inc Proteinas de fusion de factor ix y metodos para producirlas y usarlas.
IL293848B1 (en) 2015-11-06 2024-10-01 Adjuvance Tech Inc Triterpene saponin analogs, methods for their production, preparations containing them and their uses
FR3051674B1 (fr) * 2016-05-31 2019-11-08 Universite De Bourgogne Lipoproteines chargees en complexes de platine pour le traitement du cancer
CN109996809A (zh) 2016-11-14 2019-07-09 诺华股份有限公司 与促融合蛋白minion相关的组合物、方法和治疗用途
WO2019079160A1 (en) 2017-10-16 2019-04-25 Adjuvance Technologies, Inc. TRITERPENIC SAPONIN ANALOGS
EP3706801A4 (en) * 2017-11-08 2022-04-06 L.E.A.F Holdings Group LLC PLATINUM COMPLEXES AND THEIR USES
US11571386B2 (en) 2018-03-30 2023-02-07 Insmed Incorporated Methods for continuous manufacture of liposomal drug products
CN112512555A (zh) 2018-05-18 2021-03-16 比奥维拉迪维治疗股份有限公司 治疗血友病a的方法
CN114163481B (zh) * 2021-12-06 2023-06-23 郑州大学 一种含铂类药物纳米囊泡及其制备方法与应用
AU2023235562A1 (en) 2022-03-14 2024-08-22 Pfizer Inc. Methods for producing an adjuvant
WO2024116096A1 (en) 2022-12-01 2024-06-06 Pfizer Inc. Pneumococcal conjugate vaccine formulations

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1162479A (en) * 1980-03-31 1984-02-21 Murray A. Kaplan Pharmaceutical formulations containing cisplatin
US5041581A (en) * 1985-10-18 1991-08-20 The University Of Texas System Board Of Regents Hydrophobic cis-platinum complexes efficiently incorporated into liposomes
US5013556A (en) * 1989-10-20 1991-05-07 Liposome Technology, Inc. Liposomes with enhanced circulation time
US5585112A (en) * 1989-12-22 1996-12-17 Imarx Pharmaceutical Corp. Method of preparing gas and gaseous precursor-filled microspheres
US5252336A (en) * 1990-04-18 1993-10-12 Takeda Chemical Industries, Ltd. Liposome composition whose liposome membrane contains a polyoxyethylene derivative
JP3220180B2 (ja) * 1991-05-23 2001-10-22 三菱化学株式会社 薬剤含有タンパク質結合リポソーム
EP0551169A1 (en) * 1992-01-10 1993-07-14 Takeda Chemical Industries, Ltd. Liposome composition and production thereof
JP2001501173A (ja) * 1996-08-23 2001-01-30 アルザ コーポレイション シスプラチン化合物を含有するリポソーム

Also Published As

Publication number Publication date
ES2208946T3 (es) 2004-06-16
AU3985697A (en) 1998-03-06
US5945122A (en) 1999-08-31
EP0929293B1 (en) 2003-10-22
DK0929293T3 (da) 2004-02-02
DE69725747T2 (de) 2004-07-29
DE69725747D1 (de) 2003-11-27
WO1998007409A1 (en) 1998-02-26
ATE252372T1 (de) 2003-11-15
CA2263455C (en) 2002-10-29
TW483759B (en) 2002-04-21
JP2001501173A (ja) 2001-01-30
AU714992B2 (en) 2000-01-13
PT929293E (pt) 2004-03-31
CA2263455A1 (en) 1998-02-26
US6126966A (en) 2000-10-03
EP0929293A1 (en) 1999-07-21

Similar Documents

Publication Publication Date Title
HK1021320A1 (en) Liposomes containing a cisplatin compound
IL142573A0 (en) Liposome-entrapped topoisomerase inhibitors
CA2267904A1 (en) Fusogenic liposome composition and method
ATE202942T1 (de) Blutverträglicher beschichteter artikel
WO1999051202A3 (en) Quinolone containing liposomes and their use as antibacterial agents
CA2155928A1 (en) Plastic articles of reduced gas transmission and method therefor
AU7980487A (en) Improved iron-based powder mixtures
AU4834393A (en) Method of forming air film on submerged surface of submerged part-carrying structure, and film structure on submerged surface
EP1291941A3 (en) Active material for battery and method of preparing the same
AU8747991A (en) A solid surface coated with a hydrophilic outer layer with covalently bonded biopolymers, a method of making such a surface, and a conjugate therefor
AU2547195A (en) Crosslinked hybrid electrolyte film and methods of making and using the same
GB2235736B (en) Bearing with dynamic pressure grooves and method for manufacturing the same
IL135694A0 (en) Polymeric fuel additive and method of making the same, and fuel containing the additive
CA2194042A1 (en) A dual type composition brake block specifically designed for use in predetermined type brake system
AU5508094A (en) Film forming solution, porous film obtained therefrom and coated material with the porous film
AU7481591A (en) Single or multiple layer foil partially composed of starch
EP0747456A3 (en) Method for providing a waterborne coating composition with improved color acceptance
CA2121237A1 (en) Tcmtb on a solid carrier in powdered form, method of manufacture and method of use
ATE218213T1 (de) Schicht mit porösem schichtbereich, eine solche schicht enthaltendes interferenzfilter sowie verfahren zu ihrer herstellung
EP0903204A3 (en) Sliding member, inner and outer blades of an electric shaver and film-forming method
AU7843687A (en) Composition on the basis of fluorinated polymers in aqueous dispersion, containing alkoxysilanes, for coating metal surfaces
AU2816497A (en) Polymeric strands with high surface area and methods for making same
PL341765A1 (en) Embossed, multiple-layer wallpaper with smooth backside and method of making same
EP1143044A4 (en) COATED DIAMOND, METHOD FOR THE PRODUCTION THEREOF AND COMPOSITE MATERIAL THEREOF CONTAINS
EP0805353A3 (en) Immunoreaction agent and process for production thereof

Legal Events

Date Code Title Description
PF Patent in force
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20080819